As a current employed engineer at a public-listed pharmaceutical company, I would regard this 24-month cap-gap relief amendments to the current 17-month extension as extremely important and necessary as long the H1-b working visa lottery competition keeps worsening. Either from the perspective of my employer and employee myself, this OPT extension program would be really essential for us as a stepstone to fulfill our American dream as needed talent in the U.S. and the industry.